Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Recurrence 1Neoplasms 1Marijuana Abuse 1Glioblastoma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 270Specimen Handling 259pembrolizumab 235Cyclophosphamide 220Radiotherapy 208Nivolumab 171Cisplatin 162Carboplatin 150Biopsy 148Radiosurgery 130fludarabine 125Blood Specimen Collection 117Gemcitabine 113Paclitaxel 111Surveys and Questionnaires 109Standard of Care 106venetoclax 97Dexamethasone 96Bevacizumab 95Radiation 88Rituximab 84Capecitabine 82Cytarabine 79Oxaliplatin 77Doxorubicin 76Drug Therapy 75durvalumab 73Ipilimumab 72fludarabine phosphate 69atezolizumab 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × nabiximols × 90 days × Clear all
NCT05629702 2026-05-05

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting
120 enrolled
CNS

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

M.D. Anderson Cancer Center

Active not recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡